Richer SP[au] - Search Results

Year	Number of Results
1983	1
1984	1
1985	1
1986	1
1987	1
1991	1
1993	1
1996	1
1997	1
1998	3
2001	1
2008	1
2009	2
2011	1
2015	1
2016	1
2020	1
2022	0

1

Ocular oxidants and antioxidant protection.

Rose RC, Richer SP, Bode AM. Rose RC, et al. Among authors: richer sp. Proc Soc Exp Biol Med. 1998 Apr;217(4):397-407. doi: 10.3181/00379727-217-44250. Proc Soc Exp Biol Med. 1998. PMID: 9521086 Review.

2

The Diabetes Visual Function Supplement Study (DiVFuSS).

Chous AP, Richer SP, Gerson JD, Kowluru RA. Chous AP, et al. Among authors: richer sp. Br J Ophthalmol. 2016 Feb;100(2):227-34. doi: 10.1136/bjophthalmol-2014-306534. Epub 2015 Jun 18. Br J Ophthalmol. 2016. PMID: 26089210 Free PMC article. Clinical Trial.

3

Is there a prevention and treatment strategy for macular degeneration?

Richer SP. Richer SP. J Am Optom Assoc. 1993 Dec;64(12):838-50. J Am Optom Assoc. 1993. PMID: 8308188 Review.

4

Foveal macular pigment dip in offspring of age-related macular degeneration patients is inversely associated with omega-3 index.

Rutledge GA, Pratt SG, Richer SP, Huntjens B, Perry CB, Pratt G, Podella C. Rutledge GA, et al. Among authors: richer sp. BMC Ophthalmol. 2020 Dec 2;20(1):473. doi: 10.1186/s12886-020-01742-0. BMC Ophthalmol. 2020. PMID: 33267825 Free PMC article.

5

A clinical review of non-age-related cataracts.

Richer SP, Yonatan E, Harper CK, McNelis M, Rudy DR, Perdue A. Richer SP, et al. Optometry. 2001 Dec;72(12):767-78. Optometry. 2001. PMID: 12363250 Review.

6

Mobility spectacles for a patient with ankylosing spondylitis.

Richer SP, Hall T. Richer SP, et al. Am J Optom Physiol Opt. 1986 Nov;63(11):927-30. doi: 10.1097/00006324-198611000-00011. Am J Optom Physiol Opt. 1986. PMID: 3789085

7

Cataract halos: a driving hazard in aging populations. Implication of the Halometer DG test for assessment of intraocular light scatter.

Babizhayev MA, Minasyan H, Richer SP. Babizhayev MA, et al. Among authors: richer sp. Appl Ergon. 2009 May;40(3):545-53. doi: 10.1016/j.apergo.2007.09.003. Epub 2008 Sep 24. Appl Ergon. 2009. PMID: 18814857

8

Tear fluid content of electrochemically active components including water soluble antioxidants.

Gogia R, Richer SP, Rose RC. Gogia R, et al. Among authors: richer sp. Curr Eye Res. 1998 Mar;17(3):257-63. doi: 10.1076/ceyr.17.3.257.5213. Curr Eye Res. 1998. PMID: 9543634

9

Water soluble antioxidants in mammalian aqueous humor: interaction with UV B and hydrogen peroxide.

Richer SP, Rose RC. Richer SP, et al. Vision Res. 1998 Oct;38(19):2881-8. doi: 10.1016/s0042-6989(98)00069-8. Vision Res. 1998. PMID: 9797984 Free article.

10

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.

Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C. Richer SP, et al. Optometry. 2011 Nov;82(11):667-680.e6. doi: 10.1016/j.optm.2011.08.008. Optometry. 2011. PMID: 22027699 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results